Todd Foley - Net Worth and Insider Trading

Todd Foley Net Worth

The estimated net worth of Todd Foley is at least $328 Million dollars as of 2024-11-29. Todd Foley is the Director, 10% Owner of Entrada Therapeutics Inc and owns about 12,568,328 shares of Entrada Therapeutics Inc (TRDA) stock worth over $249 Million. Todd Foley is the Director of Rhythm Pharmaceuticals Inc and owns about 909,258 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $57 Million. Todd Foley is also the Director of Repare Therapeutics Inc and owns about 6,753,780 shares of Repare Therapeutics Inc (RPTX) stock worth over $22 Million. Details can be seen in Todd Foley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Todd Foley has not made any transactions after 2021-11-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Todd Foley

Todd Foley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Todd Foley owns 23 companies in total, including Turmeric Acquisition Corp (TMPMU) , Oncorus Inc (ONCR) , and Dyne Therapeutics Inc (DYN) among others .

Click here to see the complete history of Todd Foley’s form 4 insider trades.

Insider Ownership Summary of Todd Foley

Ticker	Comapny	Transaction Date	Type of Owner
TMPMU	Turmeric Acquisition Corp	2020-10-15	President
ONCR	Oncorus Inc	2020-10-01	10 percent owner
DYN	Dyne Therapeutics Inc	2020-09-16	10 percent owner
		2020-07-23	10 percent owner
		2021-03-15	director & 10 percent owner
		2021-07-12	director & 10 percent owner
		2020-06-11	director
		2019-02-13	10 percent owner
		2019-02-07	10 percent owner
		2011-11-18	10 percent owner
		2016-03-02	10 percent owner
		2015-10-14	10 percent owner
		2014-04-22	10 percent owner
		2014-03-10	10 percent owner
		2013-05-30	10 percent owner
		2014-01-29	director
		2013-07-24	10 percent owner
		2011-11-21	10 percent owner
		2012-05-23	director
		2012-01-26	other: Former 10% stockholder
		2022-06-02	director & 10 percent owner
		2021-04-29	10 percent owner
		2020-10-15	President

Todd Foley Latest Holdings Summary

Todd Foley currently owns a total of 3 stocks. Among these stocks, Todd Foley owns 12,568,328 shares of Entrada Therapeutics Inc (TRDA) as of November 2, 2021, with a value of $249 Million and a weighting of 75.93%. Todd Foley owns 909,258 shares of Rhythm Pharmaceuticals Inc (RYTM) as of March 15, 2021, with a value of $57 Million and a weighting of 17.24%. Todd Foley also owns 6,753,780 shares of Repare Therapeutics Inc (RPTX) as of July 12, 2021, with a value of $22 Million and a weighting of 6.83%.

Latest Holdings of Todd Foley

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TRDA	Entrada Therapeutics Inc	2021-11-02	12,568,328	19.83	249,229,944
RYTM	Rhythm Pharmaceuticals Inc	2021-03-15	909,258	62.25	56,601,311
RPTX	Repare Therapeutics Inc	2021-07-12	6,753,780	3.32	22,422,550

Holding Weightings of Todd Foley

Todd Foley Form 4 Trading Tracker

According to the SEC Form 4 filings, Todd Foley has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 100,000 shares on November 2, 2021, which cost Todd Foley around $2 Million.

According to the SEC Form 4 filings, Todd Foley has made a total of 19 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 1,000,000 shares on March 15, 2021, which brought Todd Foley around $25 Million.

According to the SEC Form 4 filings, Todd Foley has made a total of 9 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Repare Therapeutics Inc is the sale of 27,351 shares on July 12, 2021, which brought Todd Foley around $917,626.

Insider Trading History of Todd Foley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Todd Foley Trading Performance

GuruFocus tracks the stock performance after each of Todd Foley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd Foley is -20.42%. GuruFocus also compares Todd Foley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd Foley within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Todd Foley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Todd Foley

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-8.45
Relative Return to S&P 500(%)	-9.59

Todd Foley Ownership Network

Ownership Network List of Todd Foley

No Data

Ownership Network Relation of Todd Foley

Todd Foley Owned Company Details

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Todd Foley is the President of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Executive Officer Luke Evnin , Chief Financial Officer Edward Hurwitz , and 10 percent owner Turmeric Management, Llc .

Turmeric Acquisition Corp (TMPMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Todd Foley is the 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncorus Inc Insider Transactions

No Available Data

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Todd Foley is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , See Remarks Oxana Beskrovnaya , and director & 10 percent owner Dirk Kersten .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 466,177 shares made by Dirk Kersten , a net sale of 330,251 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .

In summary, during the past 3 months, insiders sold 548,479 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 516,479 shares. During the past 18 months, 8,028,019 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,281,734 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dyne Therapeutics Inc Insider Transactions

No Available Data

What does ITeos Therapeutics Inc do?

Who are the key executives at ITeos Therapeutics Inc?

Todd Foley is the 10 percent owner of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Joseph Lewis , and other: See remarks Boxer Asset Management Inc. .

ITeos Therapeutics Inc (ITOS) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net purchase of 10,000 shares made by Matthew Gall , and a net sale of 350,000 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 350,000 shares of ITeos Therapeutics Inc (ITOS) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 340,000 shares.

ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

ITeos Therapeutics Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Todd Foley is the director & 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include EVP & Head of North America Jennifer Chien , Chief Technical Officer Joseph Shulman , and Chief Human Resources Officer Pamela J. Cramer .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 183,308 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 183,308 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Repare Therapeutics Inc do?

Who are the key executives at Repare Therapeutics Inc?

Todd Foley is the director & 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .

Repare Therapeutics Inc (RPTX) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Repare Therapeutics Inc Insider Transactions

No Available Data

What does Chiasma Inc do?

Who are the key executives at Chiasma Inc?

Todd Foley is the director of Chiasma Inc. Other key executives at Chiasma Inc include director & Chief Executive Officer Raj Kannan , EVP & Chief Commerical Officer Anand Varadan , and President Mark J. Fitzpatrick .

Chiasma Inc (CHMA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chiasma Inc (CHMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chiasma Inc (CHMA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chiasma Inc (CHMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chiasma Inc Insider Transactions

No Available Data

What does TCR2 Therapeutics Inc do?

Who are the key executives at TCR2 Therapeutics Inc?

Todd Foley is the 10 percent owner of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin C Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .

TCR2 Therapeutics Inc (TCRR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TCR2 Therapeutics Inc (TCRR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

TCR2 Therapeutics Inc Insider Transactions

No Available Data

What does Harpoon Therapeutics Inc do?

Who are the key executives at Harpoon Therapeutics Inc?

Todd Foley is the 10 percent owner of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .

Harpoon Therapeutics Inc (HARP) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Harpoon Therapeutics Inc (HARP). Other recent insider transactions involving Harpoon Therapeutics Inc (HARP) include a net purchase of 21,397,205 shares made by Merck & Co., Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 21,397,205 shares were bought by its insiders, resulting in a net purchase of 21,397,205 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Harpoon Therapeutics Inc Insider Transactions

No Available Data

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Todd Foley is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Todd Foley is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 158,565 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 242,142 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 240,892 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Todd Foley is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 34,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,164 shares were bought by its insiders, resulting in a net sale of 14,184 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Todd Foley is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Patrick J Kerins , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Aratana Therapeutics Inc do?

Who are the key executives at Aratana Therapeutics Inc?

Todd Foley is the 10 percent owner of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Aratana Therapeutics Inc (PETX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aratana Therapeutics Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Todd Foley is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Todd Foley is the director of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Todd Foley is the 10 percent owner of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Histogen Inc Insider Transactions

No Available Data

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

Todd Foley is the 10 percent owner of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .

In summary, during the past 3 months, insiders sold 500 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 212,376 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 191,400 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacira BioSciences Inc Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

Todd Foley is the director of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Todd Foley is the other: Former 10% stockholder of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 668 shares made by Daniel Calkins , a net sale of 20,888 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 2,695 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,695 shares. During the past 18 months, 33,122 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,122 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verastem Inc Insider Transactions

No Available Data

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Todd Foley is the director & 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Scientific Officer Natarajan Sethuraman , Chief Financial Officer Kory James Wentworth , and Chief Operating Officer Nathan J Dowden .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Todd Foley made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 58,626 shares made by Kory James Wentworth , and a net sale of 64,266 shares made by Natarajan Sethuraman .

In summary, during the past 3 months, insiders sold 41,152 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 41,152 shares. During the past 18 months, 219,518 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 174,150 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entrada Therapeutics Inc Insider Transactions

No Available Data

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Todd Foley is the 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Werewolf Therapeutics Inc Insider Transactions

No Available Data

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Turmeric Acquisition Corp (TMPM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

Todd Foley Mailing Address

Above is the net worth, insider trading, and ownership report for Todd Foley. You might contact Todd Foley via mailing address: The John Hancock Tower, 200 Clarendon Street 54th Floor, Boston Ma 02116.

Discussions on Todd Foley

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.